• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

总预测 MHC-I 表位负荷与 SARS-CoV-2 导致的人群死亡率呈负相关。

Total predicted MHC-I epitope load is inversely associated with population mortality from SARS-CoV-2.

机构信息

School of Molecular Sciences, Arizona State University, Tempe, AZ 85281, USA.

Biodesign Institute, Tempe, AZ 85281, USA.

出版信息

Cell Rep Med. 2021 Mar 16;2(3):100221. doi: 10.1016/j.xcrm.2021.100221. Epub 2021 Feb 25.

DOI:10.1016/j.xcrm.2021.100221
PMID:33649748
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7904449/
Abstract

Polymorphisms in MHC-I protein sequences across human populations significantly affect viral peptide binding capacity, and thus alter T cell immunity to infection. In the present study, we assess the relationship between observed SARS-CoV-2 population mortality and the predicted viral binding capacities of 52 common MHC-I alleles. Potential SARS-CoV-2 MHC-I peptides are identified using a consensus MHC-I binding and presentation prediction algorithm called EnsembleMHC. Starting with nearly 3.5 million candidates, we resolve a few hundred highly probable MHC-I peptides. By weighing individual MHC allele-specific SARS-CoV-2 binding capacity with population frequency in 23 countries, we discover a strong inverse correlation between predicted population SARS-CoV-2 peptide binding capacity and mortality rate. Our computations reveal that peptides derived from the structural proteins of the virus produce a stronger association with observed mortality rate, highlighting the importance of S, N, M, and E proteins in driving productive immune responses.

摘要

人群中 MHC-I 蛋白序列的多态性显著影响病毒肽结合能力,从而改变了对感染的 T 细胞免疫。在本研究中,我们评估了观察到的 SARS-CoV-2 人群死亡率与 52 个常见 MHC-I 等位基因预测的病毒结合能力之间的关系。使用一种称为 EnsembleMHC 的共识 MHC-I 结合和呈递预测算法来鉴定潜在的 SARS-CoV-2 MHC-I 肽。从近 350 万个候选物开始,我们确定了几百个高度可能的 MHC-I 肽。通过在 23 个国家/地区以个体 MHC 等位基因特异性 SARS-CoV-2 结合能力与种群频率为权重,我们发现预测的人群 SARS-CoV-2 肽结合能力与死亡率之间存在很强的负相关关系。我们的计算表明,来自病毒结构蛋白的肽与观察到的死亡率之间存在更强的关联,突出了 S、N、M 和 E 蛋白在驱动有效免疫反应中的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afb1/7974549/4d0bdd261fec/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afb1/7974549/f81c99a1e2a9/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afb1/7974549/221f21b749e3/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afb1/7974549/56de46d1c706/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afb1/7974549/4d0bdd261fec/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afb1/7974549/f81c99a1e2a9/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afb1/7974549/221f21b749e3/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afb1/7974549/56de46d1c706/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afb1/7974549/4d0bdd261fec/gr4.jpg

相似文献

1
Total predicted MHC-I epitope load is inversely associated with population mortality from SARS-CoV-2.总预测 MHC-I 表位负荷与 SARS-CoV-2 导致的人群死亡率呈负相关。
Cell Rep Med. 2021 Mar 16;2(3):100221. doi: 10.1016/j.xcrm.2021.100221. Epub 2021 Feb 25.
2
Population-Predicted MHC Class II Epitope Presentation of SARS-CoV-2 Structural Proteins Correlates to the Case Fatality Rates of COVID-19 in Different Countries.人群预测的 SARS-CoV-2 结构蛋白 MHC II 表位呈递与不同国家 COVID-19 的病死率相关。
Int J Mol Sci. 2021 Mar 5;22(5):2630. doi: 10.3390/ijms22052630.
3
Assessment of SARS-CoV-2 specific CD4(+) and CD8 (+) T cell responses using MHC class I and II tetramers.使用 MHC Ⅰ类和Ⅱ类四聚体评估 SARS-CoV-2 特异性 CD4(+)和 CD8 (+) T 细胞应答。
Vaccine. 2021 Apr 8;39(15):2110-2116. doi: 10.1016/j.vaccine.2021.03.008. Epub 2021 Mar 5.
4
Identification of SARS-CoV-2 Nucleocapsid and Spike T-Cell Epitopes for Assessing T-Cell Immunity.鉴定 SARS-CoV-2 核衣壳和刺突 T 细胞表位以评估 T 细胞免疫。
J Virol. 2021 Feb 24;95(6). doi: 10.1128/JVI.02002-20.
5
Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2.人类白细胞抗原易感性图谱与严重急性呼吸综合征冠状病毒 2。
J Virol. 2020 Jun 16;94(13). doi: 10.1128/JVI.00510-20.
6
Immunoinformatics prediction of overlapping CD8 T-cell, IFN-γ and IL-4 inducer CD4 T-cell and linear B-cell epitopes based vaccines against COVID-19 (SARS-CoV-2).基于免疫信息学预测的针对 COVID-19(SARS-CoV-2)的重叠 CD8 T 细胞、IFN-γ 和 IL-4 诱导性 CD4 T 细胞和线性 B 细胞表位的疫苗。
Vaccine. 2021 Feb 12;39(7):1111-1121. doi: 10.1016/j.vaccine.2021.01.003. Epub 2021 Jan 18.
7
Identification and validation of 174 COVID-19 vaccine candidate epitopes reveals low performance of common epitope prediction tools.鉴定和验证 174 种 COVID-19 疫苗候选表位揭示了常见表位预测工具的低性能。
Sci Rep. 2020 Nov 24;10(1):20465. doi: 10.1038/s41598-020-77466-4.
8
COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations.基于全球人群中 HLA Ⅰ类基因座(HLA-A、-B、-C)分布的 COVID-19 冠状病毒疫苗 T 细胞表位预测分析。
Hum Vaccin Immunother. 2021 Apr 3;17(4):1097-1108. doi: 10.1080/21645515.2020.1823777. Epub 2020 Nov 11.
9
In silico analysis of MHC-I restricted epitopes of Chikungunya virus proteins: Implication in understanding anti-CHIKV CD8(+) T cell response and advancement of epitope based immunotherapy for CHIKV infection.基孔肯雅病毒蛋白的MHC-I限制性表位的计算机分析:对理解抗基孔肯雅病毒CD8(+) T细胞反应及基孔肯雅病毒感染的表位免疫疗法进展的意义
Infect Genet Evol. 2015 Apr;31:118-26. doi: 10.1016/j.meegid.2015.01.017. Epub 2015 Jan 31.
10
Identification of Novel Candidate Epitopes on SARS-CoV-2 Proteins for South America: A Review of HLA Frequencies by Country.鉴定 SARS-CoV-2 蛋白在南美的新型候选表位:按国家/地区分析 HLA 频率的综述。
Front Immunol. 2020 Sep 3;11:2008. doi: 10.3389/fimmu.2020.02008. eCollection 2020.

引用本文的文献

1
The dawn of biophysical representations in computational immunology.计算免疫学中生物物理表征的曙光。
QRB Discov. 2025 May 28;6:e19. doi: 10.1017/qrd.2025.7. eCollection 2025.
2
Pathogen Adaptation of HLA Alleles and Its Correlation with Autoimmune Diseases in the Han Chinese.汉族人群中HLA等位基因的病原体适应性及其与自身免疫性疾病的相关性
Genomics Proteomics Bioinformatics. 2025 May 30;23(2). doi: 10.1093/gpbjnl/qzaf038.
3
Coronavirus replicase epitopes induce cross-reactive CD8 T cell responses in SARS-CoV-2-naive people with HIV-1.

本文引用的文献

1
Immunoinformatics: Predicting Peptide-MHC Binding.免疫信息学:预测肽-MHC结合
Annu Rev Biomed Data Sci. 2020 Jul;3:191-215. doi: 10.1146/annurev-biodatasci-021920-100259. Epub 2020 Apr 27.
2
Identification and validation of 174 COVID-19 vaccine candidate epitopes reveals low performance of common epitope prediction tools.鉴定和验证 174 种 COVID-19 疫苗候选表位揭示了常见表位预测工具的低性能。
Sci Rep. 2020 Nov 24;10(1):20465. doi: 10.1038/s41598-020-77466-4.
3
MHCflurry 2.0: Improved Pan-Allele Prediction of MHC Class I-Presented Peptides by Incorporating Antigen Processing.
冠状病毒复制酶表位在未感染新冠病毒的HIV-1感染者中诱导交叉反应性CD8 T细胞应答。
iScience. 2025 Feb 3;28(3):111949. doi: 10.1016/j.isci.2025.111949. eCollection 2025 Mar 21.
4
An Expanding Universe of Mutational Signatures and Its Rapid Evolution in Single-Stranded RNA Viruses.单链RNA病毒中突变特征的不断扩展及其快速进化
Mol Biol Evol. 2025 Feb 3;42(2). doi: 10.1093/molbev/msaf009.
5
APE-Gen2.0: Expanding Rapid Class I Peptide-Major Histocompatibility Complex Modeling to Post-Translational Modifications and Noncanonical Peptide Geometries.APE-Gen2.0:将快速 I 类肽-主要组织相容性复合物建模扩展到翻译后修饰和非典型肽结构。
J Chem Inf Model. 2024 Mar 11;64(5):1730-1750. doi: 10.1021/acs.jcim.3c01667. Epub 2024 Feb 28.
6
State of the art in epitope mapping and opportunities in COVID-19.表位作图的现状与 COVID-19 中的机遇
Future Sci OA. 2023 Feb;16(3-06):FSO832. doi: 10.2144/fsoa-2022-0048. Epub 2023 Mar 6.
7
Functional studies of HLA and its role in SARS-CoV-2: Stimulating T cell response and vaccine development.HLA 的功能研究及其在 SARS-CoV-2 中的作用:刺激 T 细胞反应和疫苗开发。
Life Sci. 2023 Feb 15;315:121374. doi: 10.1016/j.lfs.2023.121374. Epub 2023 Jan 6.
8
CryoFold: determining protein structures and data-guided ensembles from cryo-EM density maps.低温折叠:从冷冻电镜密度图确定蛋白质结构和数据引导的集合体。
Matter. 2021 Oct 6;4(10):3195-3216. doi: 10.1016/j.matt.2021.09.004. Epub 2021 Sep 22.
9
Can machines learn the mutation signatures of SARS-CoV-2 and enable viral-genotype guided predictive prognosis?机器能否学习 SARS-CoV-2 的突变特征,并实现基于病毒基因型的预测预后?
J Mol Biol. 2022 Aug 15;434(15):167684. doi: 10.1016/j.jmb.2022.167684. Epub 2022 Jun 11.
10
Peculiarities of the T Cell Immune Response in COVID-19.新型冠状病毒肺炎中T细胞免疫反应的特点
Vaccines (Basel). 2022 Feb 4;10(2):242. doi: 10.3390/vaccines10020242.
MHCflurry 2.0:通过纳入抗原加工提高 MHC I 类呈递肽的泛等位基因预测。
Cell Syst. 2020 Jul 22;11(1):42-48.e7. doi: 10.1016/j.cels.2020.06.010. Epub 2020 Jul 14.
4
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.COVID-19 和 SARS 病例以及未感染对照者的 SARS-CoV-2 特异性 T 细胞免疫。
Nature. 2020 Aug;584(7821):457-462. doi: 10.1038/s41586-020-2550-z. Epub 2020 Jul 15.
5
Factors associated with COVID-19-related death using OpenSAFELY.使用 OpenSAFELY 分析与 COVID-19 相关死亡的因素。
Nature. 2020 Aug;584(7821):430-436. doi: 10.1038/s41586-020-2521-4. Epub 2020 Jul 8.
6
COVIDep: a web-based platform for real-time reporting of vaccine target recommendations for SARS-CoV-2.COVIDep:一个用于实时报告严重急性呼吸综合征冠状病毒2疫苗靶点建议的基于网络的平台。
Nat Protoc. 2020 Jul;15(7):2141-2142. doi: 10.1038/s41596-020-0358-9.
7
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals.COVID-19 疾病患者和未接触者体内针对 SARS-CoV-2 冠状病毒的 T 细胞反应的靶标。
Cell. 2020 Jun 25;181(7):1489-1501.e15. doi: 10.1016/j.cell.2020.05.015. Epub 2020 May 20.
8
Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study.牛津皇家全科医生学院研究和监测中心初级保健网络中 SARS-CoV-2 患者的风险因素:一项横断面研究。
Lancet Infect Dis. 2020 Sep;20(9):1034-1042. doi: 10.1016/S1473-3099(20)30371-6. Epub 2020 May 15.
9
Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2.人类白细胞抗原易感性图谱与严重急性呼吸综合征冠状病毒 2。
J Virol. 2020 Jun 16;94(13). doi: 10.1128/JVI.00510-20.
10
HLA studies in the context of coronavirus outbreaks.冠状病毒爆发背景下的人类白细胞抗原研究。
Swiss Med Wkly. 2020 Apr 16;150:w20248. doi: 10.4414/smw.2020.20248. eCollection 2020 Apr 6.